Islet cell failure in type 2 diabetes
Open accessThe DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index; none of the 272 sources its claims cite is checked for support yet.
Abstract
The major focus of this Review is on the mechanisms of islet beta cell failure in the pathogenesis of obesity-associated type 2 diabetes (T2D). As this demise occurs within the context of beta cell compensation for insulin resistance, consideration is also given to the mechanisms involved in the compensation process, including mechanisms for expansion of beta cell mass and for enhanced beta cell performance. The importance of genetic, intrauterine, and environmental factors in the determination of "susceptible" islets and overall risk for T2D is reviewed. The likely mechanisms of beta cell failure are discussed within the two broad categories: those with initiation and those with progression roles.
Overview
CoChat Summary
## TL;DR
This is a 2006 review arguing that type 2 diabetes develops when insulin-resistant islets can no longer sustain compensatory b cell function, leading first to dysfunction and then progressive loss of b cell mass. It emphasizes that “susceptible” islets are shaped by genetic, intrauterine, and environmental factors, and that hyperglycemia accelerates damage through glucotoxic and glucolipotoxic mechanisms.
## Key findings
- In longitudinal studies, insulin levels rise during the normoglycemic and prediabetes phases and then decline when fasting glycemia exceeds the upper normal limit of 5.5 mM, marking b cell failure.
- A longitudinal study in Pima Indians found that b cell dysfunction was the major determinant of progression from normoglycemia to diabetes.
- In autopsy pancreata from 124 subjects, the paper reports a 40% and 63% loss of islet b cell volume in obese subjects with impaired fasting glucose and T2D, respectively, compared with weight-matched controls; lean T2D subjects had a 41% loss versus lean controls.
- The paper reports that the STOP-NIDDM trial showed acarbose treatment of IGT subjects reduced the risk of progression to diabetes by 36%.
## Methods
- Narrative review of mechanistic, animal, human postmortem, genetic, and epidemiologic studies on islet b cell compensation and failure in obesity-associated T2D.
- Synthesizes findings from rodent models (including ZF, ZDF, DBA2, GK, and IUGR models) and human islet/pancreas studies, including a transcript profiling study of 7 normal and 5 T2D human islet samples.
- Main analysis is integrative and conceptual: it organizes evidence into mechanisms that promote compensation and mechanisms with initiation versus progression roles in b cell failure.
## Limitations
- The paper states that the mechanisms of b cell compensation are “not fully understood,” and that the role of several proposed factors remains to be established or warrants further investigation.
- It explicitly notes uncertainty about several mechanisms, including whether nonimmune islet inflammation contributes in vivo, whether IAPP is causal in b cell dysfunction and demise, and whether reduced ARNT expression is an early defect or a consequence.
- Evident from the text: this is a review, not a new experimental study, so its conclusions depend on the quality and consistency of the cited animal and human studies rather than on a single primary dataset.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 164 Not checked · 38 Own results and interpretations
In the paper
“Longitudinal studies of subjects that develop T2D show a rise in insulin levels in the normoglycemic and prediabetes phases that keep glycemia near normal despite the insulin resistance ( b cell compensation), followed by a decline when fasting glycemia surpasses the upper limit of normal of 5.5 mM ( b cell failure) (5) (Figure 1).”
What the sources say
- Not checked yetcites [5]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“With respect to the latter, increases were observed in enzymes and metabolites involved in anaplerosis and the malate-pyruvate and citratepyruvate shuttles of ZF islets (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Inhibition of these pathways by phenylacetic acid, which inhibits PC, markedly impeded GSIS (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Studies of islet b cell compensation within models that maintain normoglycemia show upregulation of glucose metabolism pathways (12, 13, 31).”
What the sources say
- Not checked yetcites [12]
- Not checked yetcites [13]
- Not checked yetcites [31]
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A recent study in Zucker fatty (ZF) rats has provided strong support for PKB activation in the b cell growth response to insulin resistance in this normoglycemic model (11).”
What the sources say
- Not checked yetcites [11]
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
116 more claims
Create a free account to see all 203 claims and to verify the 272 references still open.
- It may state two separate claims as one. 71
- Probably not a substantial claim. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, several of these studies have demonstrated that fatty acids do not induce beta-cell dysfunction in the absence of elevated glucose, highlighting that fatty acids and glucose are not cytotoxic independently.168,169”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [169]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, impairment of insulin secretion in the presence of an intact β-cell mass also occurs in the early stages of human age-related diabetes123.”
From The telomere syndromes (2012) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [75]
Experimental — accuracy not yet measured
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Barker, D. J. P., Hales, C. N., Fall, C. H. D., Osmond, C., Phipps, K., & Clark, P. M. S. (1993) · Diabetologia · doi:10.1007/bf00399095 · Cited by 2,468
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Cited by
Items 201–300 of 1,002
Tahara, A., Kurosaki, E., Yokono, M., Yamajuku, D., Kihara, R., Hayashizaki, Y., Takasu, T., Imamura, M., Li, Q., Tomiyama, H., et al. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0713-z · Cited by 125
Glucagon secretion from pancreatic α-cells
Briant, L., Salehi, A., Vergari, E., Zhang, Q., & Rorsman, P. (2016) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2016.1156789 · Cited by 109
“This pathological response is commonly attributed to a combination of insulin resistance and a failure of pancreatic b-cells to release insulin as required (11).”
BackgroundNon-Coding RNA: Role in Gestational Diabetes Pathophysiology and Complications
Filardi, T., Catanzaro, G., Mardente, S., Zicari, A., Santangelo, C., Lenzi, A., Morano, S., & Ferretti, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114020 · Cited by 120
“Largely, alterations at each step of insulin synthesis or secretion have been described, and β-cell dysfunction is triggered by hyperglycemia and hyperlipidemia [29].”
BackgroundG Protein–Coupled Receptors Targeting Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus
Riddy, D. M., Delerive, P., Summers, R. J., Sexton, P. M., & Langmead, C. J. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014373 · Cited by 108
“However, analysis of rare loss-of-function MTNR1B variants suggested that reduced MT signaling increases T2DM risk (Prokopenko et al., 2009; Bonnefond et al., 2012).”
BackgroundIslet‐cell‐to‐cell communication as basis for normal insulin secretion
Bavamian, S., Klee, P., Britan, A., Populaire, C., Caille, D., Cancela, J., Charollais, A., & Meda, P. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00780.x · Cited by 108
Self-adjusting synthetic gene circuit for correcting insulin resistance
Ye, H., Xie, M., Xue, S., Hamri, G. C., Yin, J., Zulewski, H., & Fussenegger, M. (2016) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0005 · Cited by 120
Estrada, E. J., Valacchi, F., Nicora, E., Brieva, S., Esteve, C., Echevarria, L., Froud, T., Bernetti, K., Messinger, S., Velazquez, O. C., et al. (2008) · Cell Transplantation · doi:10.3727/096368908787648119 · Cited by 111
Deep Insight of the Pathophysiology of Gestational Diabetes Mellitus
Sharma, A. K., Singh, S., Singh, H., Mahajan, D., Kolli, P., Mandadapu, G., Kumar, B., Kumar, D., Kumar, S., & Jena, M. K. (2022) · Cells · doi:10.3390/cells11172672 · Cited by 146
“Recent studies have shown that genes, such as the potassium voltage-gated channel KQT-like 1 (Kcnq1) and Glucokinase (Gck), are susceptible to β-cell function and responsible to cause GDM in pregnant women [57].”
BackgroundNutritional regulation of insulin secretion: implications for diabetes.
Newsholme, P., & Krause, M. D. S. (2012) · Europe PMC (PubMed Central) · Cited by 145
Douillet, C., Currier, J., Saunders, J., Bodnar, W. M., Matoušek, T., & Stýblo, M. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.12.007 · Cited by 104
“The continued insulin resistance ultimately leads to the pancreatic β-cell failure (Prentki and Nolan, 2006).”
Sun, J., Ni, Q., Xie, J., Xu, M., Zhang, J., Kuang, J., Wang, Y., Ning, G., & Wang, Q. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00968 · Cited by 107
pVHL is a regulator of glucose metabolism and insulin secretion in pancreatic β cells
Zehetner, J., Danzer, C., Collins, S., Eckhardt, K., Gerber, P. A., Ballschmieter, P., Galvanovskis, J., Shimomura, K., Ashcroft, F. M., Thorens, B., et al. (2008) · Genes & Development · doi:10.1101/gad.496908 · Cited by 104
Miao, X., Gu, Z., Liu, P., Hu, Y., Li, L., Gong, Y., Shu, H., Liu, Y., & Li, C. (2012) · Peptides · doi:10.1016/j.peptides.2012.10.006 · Cited by 115
Alarcón, C., Boland, B. B., Uchizono, Y., Moore, P. C., Peterson, B. F., Rajan, S., Rhodes, O. S., Noske, A. B., Haataja, L., Arvan, P., et al. (2015) · Diabetes · doi:10.2337/db15-0792 · Cited by 108
Miki, A., Ricordi, C., Sakuma, Y., Yamamoto, T., Misawa, R., Mita, A., Molano, R. D., Vaziri, N. D., Pileggi, A., & Ichii, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196570 · Cited by 114
Zhang, T., Li, L., Shang, Q., Lv, C., Wang, C., & Su, B. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.017 · Cited by 103
Mild suppression of hyperinsulinemia to treat obesity and insulin resistance
Page, M. M., & Johnson, J. D. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.03.018 · Cited by 99
Maedler, K., Schulthess, F. T., Bielman, C., Berney, T., Bonny, C., Prentki, M., Donath, M. Y., & Roduit, R. (2008) · The FASEB Journal · doi:10.1096/fj.07-101824 · Cited by 99
Self-citationThe involvement of microRNAs in Type 2 diabetes
Ferland-McCollough, D., Ozanne, S. E., Siddle, K., Willis, A. E., & Bushell, M. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381565 · Cited by 107
Fontés, G., Zarrouki, B., Hagman, D. K., Latour, M. G., Semache, M., Roskens, V., Moore, P. C., Prentki, M., Rhodes, C. J., Jetton, T. L., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1850-5 · Cited by 99
Self-citationShort Telomeres Compromise β-Cell Signaling and Survival
Guo, N., Parry, E. M., Li, L.-S., Kembou, F., Lauder, N., Hussain, M. A., Berggren, P.-O., & Armanios, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017858 · Cited by 100
Aberrant islet unfolded protein response in type 2 diabetes
Engin, F., Nguyen, T., Yermalovich, A., & Hotamisligil, G. S. (2014) · Scientific Reports · doi:10.1038/srep04054 · Cited by 98
Pancreatic islet inflammation in type 2 diabetes: From α and β cell compensation to dysfunction
Ehses, J. A., Ellingsgaard, H., Böni-Schnetzler, M., & Donath, M. Y. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450903025879 · Cited by 97
Templeman, N. M., Clee, S. M., & Johnson, J. D. (2015) · Diabetologia · doi:10.1007/s00125-015-3676-7 · Cited by 96
Imai, Y., Cousins, R. S., Liu, S., Phelps, B. M., & Promes, J. A. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14037 · Cited by 100
“6,35 In brief, three key supporting arguments include (1) rapid formation of glycerolipids in response to glucose (as discussed above), (2) generation of metabolites known to modulate insulin secretion by the cycle, and (3) reduction of GSIS by suppression of lipolysis.”
BackgroundRecent advances in nonalcholic fatty liver disease
Greenfield, V., Cheung, O., & Sanyal, A. J. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282fbccf2 · Cited by 94
Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications
Willmer, T., Johnson, R., Louw, J., & Pheiffer, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00744 · Cited by 107
Cardiometabolic Risk Factors Associated With Type 2 Diabetes Mellitus: A Mechanistic Insight
Chakraborty, S., Verma, A., Garg, R., Singh, J., & Verma, H. (2023) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514231220780 · Cited by 150
“111 In addition to the liver, skeletal muscle, and pancreatic cells, which under normal circumstances do not store lipids, fat storage occurs inside and around these organs when the diet-derived fat intake is increased that ultimately leads to an excessive generation in the mitochondria of…”
BackgroundPietropaolo, M., Barinas-Mitchell, E., & Kuller, L. H. (2007) · Diabetes · doi:10.2337/db06-0880 · Cited by 94
Seiva, F. R. F., Chuffa, L. G. D. A., Braga, C. P., Amorim, J. P. D. A., & Fernandes, A. A. H. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.07.009 · Cited by 95
Plaisance, V., Brajkovic, S., Tenenbaum, M., Favre, D., Ezanno, H., Bonnefond, A., Bonner, C., Gmyr, V., Kerr-Conte, J. A., Gauthier, B. R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163046 · Cited by 99
El-Assaad, W., Joly, E., Barbeau, A., Sladek, R., Buteau, J., Maestre, I., Pepin, E., Zhao, S., Iglesias, J., Roche, E., et al. (2010) · Endocrinology · doi:10.1210/en.2009-1238 · Cited by 93
Self-citationIslet-1 Is Essential for Pancreatic β-Cell Function
Ediger, B. N., Du, A., Liu, J., Hunter, C. S., Walp, E. R., Schug, J., Kaestner, K. H., Stein, R. W., Stoffers, D. A., & May, C. L. (2014) · Diabetes · doi:10.2337/db14-0096 · Cited by 100
Inhibition of PKCɛ Improves Glucose-Stimulated Insulin Secretion and Reduces Insulin Clearance
Schmitz‐Peiffer, C., Laybutt, D. R., Burchfield, J. G., Gurisik, E., Narasimhan, S. R., Mitchell, C. J., Pedersen, D. J., Braun, U., Cooney, G. J., Leitges, M., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.012 · Cited by 114
Liu, Z., Tanabe, K., Bernal‐Mizrachi, E., & Permutt, M. A. (2008) · Diabetologia · doi:10.1007/s00125-007-0914-7 · Cited by 104
Phenotypic characteristics of early Wolfram syndrome
Marshall, B. A., Permutt, M. A., Paciorkowski, A. R., Hoekel, J., Karzon, R., Wasson, J., Viehover, A., White, N. H., Shimony, J. S., Manwaring, L., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-64 · Cited by 93
“These factors impinge on pancreatic β-cells resulting in ER stress, oxidative stress, impaired signal transduction, and mitochondrial dysfunction, all combining to result in β-cell apoptosis and diabetes[10-13].”
BackgroundHyperinsulinemia Precedes Insulin Resistance in Mice Lacking Pancreatic β-Cell Leptin Signaling
Gray, S. L., Donald, C., Jetha, A., Covey, S. D., & Kieffer, T. J. (2010) · Endocrinology · doi:10.1210/en.2010-0102 · Cited by 92
Minireview: Autophagy in Pancreatic β-Cells and Its Implication in Diabetes
Watada, H., & Fujitani, Y. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1367 · Cited by 98
FoxM1 Is Up-Regulated by Obesity and Stimulates β-Cell Proliferation
Davis, D. B., Lavine, J. A., Suhonen, J. I., Krautkramer, K. A., Rabaglia, M. E., Sperger, J. M., Fernandez, L. A., Yandell, B. S., Keller, M. P., Wang, I.-M., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0082 · Cited by 91
Pancreatic steatosis in humans: cause or marker of lipotoxicity?
van Raalte, D. H., van der Zijl, N. J., & Diamant, M. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833aa1ef · Cited by 90
Age-related diseases as vicious cycles
Belikov, A. V. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2018.11.002 · Cited by 90
m6A mRNA Methylation Controls Functional Maturation in Neonatal Murine β-Cells
Wang, Y., Sun, J., Lin, Z., Zhang, W., Wang, S., Wang, W., Wang, Q., & Ning, G. (2020) · Diabetes · doi:10.2337/db19-0906 · Cited by 98
Shen, N., Yu, X., Pan, F., Gao, X., Xue, B., & Li, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190165 · Cited by 92
Cholesterol induces pancreatic β cell apoptosis through oxidative stress pathway
Lu, X., Liu, J., Hou, F., Liu, Z., Cao, X., Seo, H., & Gao, B. (2011) · Cell Stress and Chaperones · doi:10.1007/s12192-011-0265-7 · Cited by 88
Zmuda, E. J., Qi, L., Zhu, M. X., Mirmira, R. G., Montminy, M. R., & Hai, T. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0463 · Cited by 90
Hanley, A. J., Retnakaran, R. R., Qi, Y., Gerstein, H. C., Perkins, B. A., Raboud, J., Harris, S. B., & Zinman, B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0719 · Cited by 105
MicroRNA-7: A miRNA with expanding roles in development and disease
Horsham, J. L., Ganda, C., Kalinowski, F. C., Brown, R. A. M., Epis, M. R., & Leedman, P. J. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.11.001 · Cited by 95
Cell size control – a mechanism for maintaining fitness and function
Miettinen, T. P., Caldez, M. J., Kaldis, P., & Björklund, M. (2017) · BioEssays · doi:10.1002/bies.201700058 · Cited by 89
“Increased cell size, such as observed during compensatory growth of pancreatic beta-cells in insulin resistance [85], may be linked to reduction in mevalonate pathway activity [10, 67], which induces an inflammatory response [86–88] (Fig.”
BackgroundFunakoshi, S., Fujimoto, S., Hamasaki, A., Fujiwara, H., Fujita, Y., Ikeda, K., Hamamoto, Y., Hosokawa, M., Seino, Y., & Inagaki, N. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.010 · Cited by 93
α-Synuclein binds the KATP channel at insulin-secretory granules and inhibits insulin secretion
Geng, X., Lou, H., Wang, J., Li, L., Swanson, A., Sun, M., Beers-Stolz, D., Watkins, S. C., Perez, R. G., & Drain, P. F. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00262.2010 · Cited by 103
Redox Control of Endoplasmic Reticulum Function
Csala, M., Margittai, É., & Bánhegyi, G. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2529 · Cited by 98
Autophagy in adipose tissue and the beta cell: implications for obesity and diabetes
Stienstra, R., Haim, Y., Riahi, Y., Netea, M. G., Rudich, A., & Leibowitz, G. (2014) · Diabetologia · doi:10.1007/s00125-014-3255-3 · Cited by 99
G-Protein-Coupled Estrogen Receptor (GPER) and Sex-Specific Metabolic Homeostasis
Sharma, G., & Prossnitz, E. R. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-70178-3_20 · Cited by 88
Catalpol in Diabetes and its Complications: A Review of Pharmacology, Pharmacokinetics, and Safety
Bai, Y., Zhu, R., Tian, Y., Li, R., Chen, B., Zhang, H., Xia, B., Zhao, D., Mo, F., Zhang, D., et al. (2019) · Molecules · doi:10.3390/molecules24183302 · Cited by 92
“The accumulated glycolipid toxicity in the development of DM may gradually lead to β-cell dysfunction and exhaustion [52,53].”
BackgroundStützer, I., Selevsek, N., Esterházy, D., Schmidt, A., Aebersold, R., & Stoffel, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.444703 · Cited by 88
“These adaptive processes require the communication of -cells with other tissues (via circulating factors) and their microenvironment that is composed of endocrine cells of the islet of Langerhans and non-endocrine cells (3, 4).”
BackgroundDisallowed and Allowed Gene Expression: Two Faces of Mature Islet Beta Cells
Lemaire, K., Thorrez, L., & Schuit, F. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050808 · Cited by 87
Why are we shaped differently, and why does it matter?
Santosa, S., & Jensen, M. D. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90357.2008 · Cited by 87
Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells
Triñanes, J., Rodríguez‐Rodríguez, A. E., Brito‐Casillas, Y., Wägner, A. M., de Vries, A. P. J., Cuesto, G., Acebes, Á., SALIDO, E. C., Torres, A., & Porrini, E. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14323 · Cited by 90
“These results are in line with publications showing that free fatty acids and impaired glucose tolerance promote changes in MafA, PDX-1, NeuroD, and FoxO1 (19,31).”
ResultEmerging roles of non‐coding RNAs in pancreatic β‐cell function and dysfunction
Guay, C., Jacovetti, C., Nesca, V., Motterle, A., Tugay, K., & Regazzi, R. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01654.x · Cited by 92
Norris, T., Cole, T. J., Bann, D., Hamer, M., Hardy, R., Li, L., Ong, K. K., Ploubidis, G. B., Viner, R., & Johnson, W. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003387 · Cited by 85
“This state leads to peripheral and hepatic insulin resistance [47,48], resulting in a compensatory insulin hypersecretion by the pancreatic β-cells in order to preserve normoglycemia [49].”
BackgroundNutritional significance and therapeutic potential of Moringa oleifera : The wonder plant
Arora, S., & Arora, S. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13933 · Cited by 104
Characterisation of Age-Dependent Beta Cell Dynamics in the Male db/db Mice
Dalbøge, L. S., Almholt, D. L. C., Neerup, T. S. R., Vassiliadis, E., Vrang, N., Pedersen, L., Fosgerau, K., & Jelsing, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082813 · Cited by 100
“Furthermore, mitochondrial dysfunction caused by reactive oxygen species (ROS) as a consequence of increased metabolism of glucose and free fatty acids is a central contributor to beta-cell apoptosis [41,50,51].”
BackgroundMehmeti, I., Lortz, S., Avezov, E., Jörns, A., & Lenzen, S. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.021 · Cited by 86
Neuronal signals regulate obesity induced β-cell proliferation by FoxM1 dependent mechanism
Yamamoto, J., Imai, J., Izumi, T., Takahashi, H., Kawana, Y., Takahashi, K., Kodama, S., Kaneko, K., Gao, J., Uno, K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01869-7 · Cited by 93
Emerging role of testosterone in pancreatic β cell function and insulin secretion
Xu, W., Morford, J., & Mauvais-Jarvis, F. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0573 · Cited by 81
Rho GTPases—Emerging Regulators of Glucose Homeostasis and Metabolic Health
Møller, L. L. V., Klip, A., & Sylow, L. (2019) · Cells · doi:10.3390/cells8050434 · Cited by 84
Li, X., Zhen, M., Zhou, C., Deng, R., Yu, T., Wu, Y., Shu, C., Wang, C., & Bai, C. (2019) · ACS Nano · doi:10.1021/acsnano.9b02050 · Cited by 85
Regulation of β‐cell mass and function by the Akt/protein kinase B signalling pathway
Elghazi, L., Rachdi, L., Weiss, A., CRAS-MÉNEUR, C. M. H., & Bernal‐Mizrachi, E. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00783.x · Cited by 103
Gupta, D., Kono, T., & Evans‐Molina, C. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01299.x · Cited by 97
FoxO1 Plays an Important Role in Regulating β-Cell Compensation for Insulin Resistance in Male Mice
Zhang, T., Kim, D. H., Xiao, X., Lee, S., Gong, Z., Muzumdar, R. H., Calabuig-Navarro, V., Yamauchi, J., Harashima, H., Wang, R., et al. (2016) · Endocrinology · doi:10.1210/en.2015-1852 · Cited by 96
Ottosson-Laakso, E., Krus, U., Storm, P., Prasad, R. B., Oskolkov, N., Ahlqvist, E., Fadista, J., Hansson, O., Groop, L., & Vikman, P. J. (2017) · Diabetes · doi:10.2337/db17-0311 · Cited by 89
From victim to ally: the kidney as an emerging target for the treatment of diabetes mellitus
Bays, H. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990802710422 · Cited by 83
Insulin resistance and gray matter volume in neurodegenerative disease
Morris, J. K., Vidoni, E. D., Perea, R. D., Rada, R., Johnson, D. K., Lyons, K., Pahwa, R., Burns, J. M., & Honea, R. A. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.006 · Cited by 83
“Enhanced beta cell function and increased insulin secretion allows normoglycemia to be maintained in response to insulin resistance (Prentki and Nolan, 2006).”
Interleukin-1 signaling contributes to acute islet compensation
Hajmrle, C., Smith, N. P., Spigelman, A. F., Dai, X.-Q., Senior, L., Bautista, A., Ferdaoussi, M., & MacDonald, P. E. (2016) · JCI Insight · doi:10.1172/jci.insight.86055 · Cited by 90
Obesity-induced overexpression of miR-802 impairs insulin transcription and secretion
Zhang, F., Ma, D., Zhao, W., Wang, D., Liu, T., Liu, Y., Yang, Y., Liu, Y., Mu, J., Li, B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15529-w · Cited by 91
Glucolipotoxicity and beta cells in type 2 diabetes mellitus: Target for durable therapy?
van Raalte, D. H., & Diamant, M. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70012-2 · Cited by 101
Cafeteria diet-induced obesity plus chronic stress alter serum leptin levels
de Macedo, I. C., Medeiros, L. F., de Oliveira, C. M., de Oliveira, C. M., Rozisky, J. R., Scarabelot, V. L., de Souza, A., Silva, F. R., Santos, V. S., Cioato, S. G., et al. (2012) · Peptides · doi:10.1016/j.peptides.2012.08.007 · Cited by 101
Turanlı, B., Karagoz, K., Sevimoğlu, T., Kılıç, E., Göv, E., & Arğa, K. Y. (2015) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2015.0088 · Cited by 92
Glucolipotoxicity in Pancreatic β-Cells
Kim, J.-W., & Yoon, K.-H. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.5.444 · Cited by 82
Downregulation of Bcl-2 Expression by miR-34a Mediates Palmitate-Induced Min6 Cells Apoptosis
Lin, X., Guan, H., Huang, Z., Liu, J., Li, H., Wei, G., Cao, X., & Li, Y. (2014) · Journal of Diabetes Research · doi:10.1155/2014/258695 · Cited by 82
Islet prohormone processing in health and disease
Chen, Y., Taylor, A. J., & Verchere, C. B. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13401 · Cited by 86
Intrauterine programming of the endocrine pancreas
Remacle, C., Dumortier, O., Bol, V., Goosse, K., Romanus, P., Theys, N., Bouckenooghe, T., & Reusens, B. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00790.x · Cited by 80
Urbanová, J., Rypáčková, B., Procházková, Z., Kučera, P., Černá, M., Anděl, M., & Heneberg, P. (2014) · Diabetic Medicine · doi:10.1111/dme.12314 · Cited by 80
Impaired peripheral glucose homeostasis and Alzheimer's disease
Wijesekara, N., Gonçalves, R. A., De Felice, F. G., & Fraser, P. E. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.027 · Cited by 80
“This beta cell compensation is mediated by expansion of beta cell mass, increased insulin biosynthesis, and enhanced nutrient secretion coupling processes with increased sensitivity to stimuli (Prentki and Nolan, 2006).”
Stem-cell based organ-on-a-chip models for diabetes research
Rogal, J., Zbinden, A., Schenke‐Layland, K., & Loskill, P. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.010 · Cited by 93
PyMINEr Finds Gene and Autocrine-Paracrine Networks from Human Islet scRNA-Seq
Tyler, S. R., Rotti, P. G., Sun, X., Yi, Y., Xie, W., Winter, M. C., Flamme-Wiese, M. J., Tucker, B. A., Mullins, R. F., Norris, A. W., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.063 · Cited by 80
“…hormone processing and secretion, dysregulated autocrine or paracrine signaling, changes to cell identity, and/or alterations in transcriptional control of these processes (Grant et al., 2006; Khodabandehloo et al., 2016; Nicolson et al., 2009; Prentki and Nolan, 2006; Rutter et al., 2015).”
Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes
Åvall, K., Ali, Y., Leibiger, I. B., Leibiger, B., Moede, T., Paschen, M., Dicker, A., Daré, E., Köhler, M., Ilegems, E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423849112 · Cited by 80
Scopinaro, N., Papadia, F. S., Marinari, G. M., Camerini, G. B., & Adami, G. F. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9045-y · Cited by 80
de Leeuw van Weenen, J. E., Parlevliet, E. T., Maechler, P., Havekes, L. M., Romijn, J. A., Ouwens, D. M., Pijl, H., & Guigas, B. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.029 · Cited by 79
Too much of a good thing: why it is bad to stimulate the beta cell to secrete insulin
Aston‐Mourney, K., Proietto, J., Morahan, G., & Andrikopoulos, S. (2008) · Diabetologia · doi:10.1007/s00125-008-0930-2 · Cited by 89
Kaneto, H., Obata, A., Kimura, T., Shimoda, M., Okauchi, S., Shimo, N., Matsuoka, T., & Kaku, K. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12494 · Cited by 92
Long Noncoding RNAs in Metabolic Syndrome Related Disorders
Łośko, M., Kotlinowski, J., & Jura, J. (2016) · Mediators of Inflammation · doi:10.1155/2016/5365209 · Cited by 94
Rangel-Azevedo, C., Santana-Oliveira, D. A., Miranda, C. S., Martins, F. F., Mandarim‐de‐Lacerda, C. A., & Souza‐Mello, V. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109002 · Cited by 95
Puerarin Protects Pancreatic β-Cells in Obese Diabetic Mice via Activation of GLP-1R Signaling
Yang, L., Yao, D., Yang, H., Wei, Y., Peng, Y., Ding, Y., & Shu, L. (2016) · Molecular Endocrinology · doi:10.1210/me.2015-1213 · Cited by 84
β-Cell failure in type 2 diabetes
Leibowitz, G., Kaiser, N., & Cerasi, E. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00094.x · Cited by 78
Adipokines and insulin action: A sensitive issue
Knights, A. J., Funnell, A. P. W., Pearson, R. C. M., Crossley, M., & Bell-Anderson, K. S. (2014) · Adipocyte · doi:10.4161/adip.27552 · Cited by 100
“A clearer and broader understanding of the interactions between adipokines and blood glucose regulation has great potential to aid in the development of therapeutic tools for insulin resistance in metabolic disorders such as obesity, metabolic syndrome, and T2DM.”
BackgroundInfluentialGlucose sensing and the pathogenesis of obesity and type 2 diabetes
Thorens, B. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.208 · Cited by 78
Shibazaki, T., Tomae, M., Ishikawa-Takemura, Y., Fushimi, N., Itoh, F., Yamada, M., & Isaji, M. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.193045 · Cited by 84
Sirdah, M. M., & Reading, N. S. (2020) · Clinical Genetics · doi:10.1111/cge.13772 · Cited by 89
“On the other hand, in T2D and due to increased peripheral insulin resistance, the β-pancreatic islets can no longer sustain higher compensatory rates of insulin production get exhausted and dysfunctional.(93,150-152) In addition, increased β-cell apoptosis leading to deficit in β-cell mass to a variable extent is also…”
BackgroundCheng, K. K. Y., Lam, K. S. L., Wu, D., Wang, Y., Sweeney, G., Hoo, R. L. C., Zhang, J., & Xu, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202435109 · Cited by 85
Metadata
- Authors
- Prentki, M.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Corresponding author
- Prentki, M.
- ORCID
- Prentki, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-07-03
- Volume
- 116
- Issue
- 7
- Pages
- 1802-1812
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1483155
- OpenAlex
- W1598254642
- Cited by
- 1,690
- References
- 132
- Citations by year
- 2026: 52 · 2025: 52 · 2024: 46 · 2023: 54 · 2022: 68 · 2021: 95 · 2020: 95 · 2019: 111 · 2018: 90 · 2017: 109 · 2016: 112 · 2015: 107 · 2014: 131 · 2013: 97 · 2012: 98
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Funders
- ACT Government
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK063356, DK63356)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- beta-cell failure, type 2 diabetes, obesity, beta-cell compensation, beta-cell mass expansion, insulin resistance, genetic susceptibility, intrauterine factors, environmental risk factors, beta-cell dysfunction
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Disease Progression, Genetic Predisposition to Disease, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.